
Overview
Wellness category firm reported fiscal Q1 revenue up 1%, beating analyst expectations
Adjusted EPS for fiscal Q1 beat analyst expectations
Company repurchased $97 mln of common shares in fiscal Q1
Outlook
BellRing narrows fiscal 2026 net sales outlook to $2.41-$2.46 bln
Company expects fiscal 2026 adjusted EBITDA of $425-$440 mln
BellRing anticipates growth acceleration in second half of fiscal 2026
Result Drivers
VOLUME AND PRICE MIX - Net sales increased by 0.8% due to a 0.7% rise in volume and a 0.1% increase in price/mix
DYMATIZE GROWTH - Dymatize net sales rose 15.8% driven by strong volume growth, especially in international markets
PREMIER PROTEIN DECLINE - Premier Protein net sales fell 1.2% due to a 1.0% decrease in price/mix and 0.2% decrease in volume
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q1 Sales | Beat | $537.30 mln | $504.56 mln (13 Analysts) |
Q1 Adjusted EPS | Beat | $0.37 | $0.32 (14 Analysts) |
Q1 EPS |
| $0.36 |
|
Q1 Adjusted EBITDA | Beat | $90.30 mln | $81.05 mln (11 Analysts) |
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 12 "strong buy" or "buy", 4 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the food processing peer group is "buy"
Wall Street's median 12-month price target for Bellring Brands Inc is $35.00, about 43.5% above its February 2 closing price of $24.39
The stock recently traded at 12 times the next 12-month earnings vs. a P/E of 13 three months ago
Press Release: ID:nGNX16YCsg
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.